Does DAPAGLIFLOZIN Cause Bladder transitional cell carcinoma? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Bladder transitional cell carcinoma have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 0.0% of all adverse event reports for DAPAGLIFLOZIN.
9
Reports of Bladder transitional cell carcinoma with DAPAGLIFLOZIN
0.0%
of all DAPAGLIFLOZIN reports
0
Deaths
6
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From DAPAGLIFLOZIN?
Of the 9 reports, 6 (66.7%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Off label use (891)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which DAPAGLIFLOZIN Alternatives Have Lower Bladder transitional cell carcinoma Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN